Interaction between chemotherapeutics and anticoagulants


View Publication Info
Field Value
Title Interaction between chemotherapeutics and anticoagulants
Creator Guerra, Federico
Description Patients with metastatic renal cell carcinoma are at increased risk of bleeding, which must be taken into account if the thromboembolic risk profile requires anticoagulant therapy. Patients treated with sunitinib, especially if with a history of hypertension or coronary artery disease, have a higher risk of cardiovascular events, therefore they should be monitored closely for evidence of worsening arterial hypertension or signs of left ventricular dysfunction. The development of some complications associated with sunitinib increases the thromboembolic risk of patients, who often have to resort to anticoagulant therapy. In the absence of specific guidelines for the management of thromboembolic risk in cancer patients, the therapeutic choice must be guided by the evidence available in the literature to support the individual pharmacological classes. We describe her the case of a patient treated with sunitinib for clear cell renal cell carcinoma, with different comorbidities. The case provides interesting clues for optimal prophylaxis of cardioembolism in cancer patient with atrial fibrillation (Cardiology).
Publisher Aboutscience Srl
Date 2018-11-06
Type info:eu-repo/semantics/article
Case report
Format application/pdf
Source AboutOpen; V. 4 N. 1 (2018): January - December 2018; 196-201
AboutOpen; Vol 4 No 1 (2018): January - December 2018; 196-201
Language eng
Rights Copyright (c) 2018 The authors

Contact Us

The PKP Index is an initiative of the Public Knowledge Project.

For PKP Publishing Services please use the PKP|PS contact form.

For support with PKP software we encourage users to consult our wiki for documentation and search our support forums.

For any other correspondence feel free to contact us using the PKP contact form.

Find Us


Copyright © 2015-2018 Simon Fraser University Library